pamidronate has been researched along with Osteitis Fibrosa Cystica in 2 studies
Osteitis Fibrosa Cystica: A fibrous degeneration, cyst formation, and the presence of fibrous nodules in bone, usually due to HYPERPARATHYROIDISM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Primary hyperparathyroidism is usually associated with normal or elevated serum 1,25-dihydroxyvitamin D [1,25(OH)2D] levels." | 1.29 | Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease. ( Brossard, JH; D'Amour, P; Garon, J; Gascon-Barré, M; Lepage, R, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bains, MA | 1 |
| Pardoe, LE | 1 |
| Rudin, CE | 1 |
| Brossard, JH | 1 |
| Garon, J | 1 |
| Lepage, R | 1 |
| Gascon-Barré, M | 1 |
| D'Amour, P | 1 |
2 other studies available for pamidronate and Osteitis Fibrosa Cystica
| Article | Year |
|---|---|
Osteitis fibrosa cystica and secondary hyperparathyroidism in multiple myeloma.
Topics: Antineoplastic Agents; Bone Marrow Cells; Diphosphonates; Female; Humans; Hyperparathyroidism, Secon | 2007 |
Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
Topics: Adenoma; Alkaline Phosphatase; Bone Resorption; Calcitonin; Calcitriol; Calcium; Calcium Carbonate; | 1993 |